Bencyclane, a vasodilator, was introduced in 1970 for the
treatment of peripheral and cerebral vascular disorders. In 1991, its use was
contraindicated by the German authorities in patients at risk of epilepsy following
reports of convulsions in patients under treatment. Bencyclane is widely registered
and the World Health Organization is not aware of restrictive action having been
taken elsewhere.